Citations (101)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Samin Alihosseini, Farzaneh Khodaei, Mehran Jaberinezhad, Mojtaba Azari, Maghsoud Ezzati Khatab, Hedieh Akhlaghi, Nima Ghanini, Mohammad Kazem Tarzamni & Elham Eghbali. (2024) Evaluation of gallbladder contractility and Doppler findings in patients with irritable bowel syndrome; a case-control study. Scandinavian Journal of Gastroenterology 59:3, pages 344-351.
Read now
Read now
Naciye Isbil-Buyukcoskun, Betul Cam, Guldal Gulec Suyen & Kasim Ozluk. (2018) Effects of intracerebroventricularly injected glucagon-like peptide-2 on ethanol-induced gastric mucosal damage in rats. Endocrine Research 43:4, pages 220-227.
Read now
Read now
Lærke Marijke Nørholk, Jens Juul Holst & Palle Bekker Jeppesen. (2012) Treatment of adult short bowel syndrome patients with teduglutide
. Expert Opinion on Pharmacotherapy 13:2, pages 235-243.
Read now
Read now
Pamela J Hornby & Beverley A Moore. (2011) The therapeutic potential of targeting the glucagon-like peptide-2 receptor in gastrointestinal disease. Expert Opinion on Therapeutic Targets 15:5, pages 637-646.
Read now
Read now
Einar Björnsson. (2009) This month in the Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 44:3, pages 259-260.
Read now
Read now
Articles from other publishers (96)
Hamdy Khaled Sabra, Gehad S. Remeih, Ibraheem M. Kereet, Mohammad Hamad, Yassmien Ali Ahmed, Kainat Jahangir, Mostafa Abdulraheem Bakr, Fatma Assad Alagelli, Hadeer Sherif & Mohamed Elsaid. (2024) Efficacy and safety of glucagon-like peptide-2 (GLP-2) in patients with short bowel syndrome; A Systematic Review and Network Meta-analysis. Journal of Gastrointestinal Surgery.
Crossref
Crossref
Kundanika Mukherjee & Changting Xiao. (2024) GLP-2 regulation of intestinal lipid handling. Frontiers in Physiology 15.
Crossref
Crossref
Kundanika MukherjeeRita WangChangting Xiao. (2024) Release of Lipids Stored in the Intestine by Glucagon-Like Peptide-2 Involves a Gut-Brain Neural Pathway. Arteriosclerosis, Thrombosis, and Vascular Biology 44:1, pages 192-201.
Crossref
Crossref
Thomas Edward Conley, Katherine Lynsey White, Ashley Bond, Simon Harrison, John McLaughlin & Simon Lal. (2023) Emerging uses of glucagon-like peptide 1 (GLP-1) receptor agonists following ileal resection: literature review and case examples. Frontline Gastroenterology 14:6, pages 521-526.
Crossref
Crossref
August Pilegaard Prahm, Mark Krogh Hvistendahl, Christopher Filtenborg Brandt, Paul Blanche, Bolette Hartmann, Jens Juul Holst & Palle Bekker Jeppesen. (2023) Post-prandial secretion of glucagon-like peptide-2 (GLP-2) after carbohydrate-, fat- or protein enriched meals in healthy subjects. Peptides 169, pages 171091.
Crossref
Crossref
Maria Buur Nordskov Gabe, Liv von Voss, Jenna Elizabeth Hunt, Sarina Gadgaard, Lærke Smidt Gasbjerg, Jens Juul Holst, Hannelouise Kissow, Bolette Hartmann & Mette Marie Rosenkilde. (2023) Biased GLP‐2 agonist with strong G protein‐coupling but impaired arrestin recruitment and receptor desensitization enhances intestinal growth in mice. British Journal of Pharmacology 180:13, pages 1674-1689.
Crossref
Crossref
Hannah M. Phelps & Brad W. Warner. (2023) Intestinal adaptation and rehabilitation. Seminars in Pediatric Surgery 32:3, pages 151314.
Crossref
Crossref
L. N. Kostyuchenko, A. E. Lychkova & M. V. Kostyuchenko. (2023) Nutritional correction after extensive combined bowel resections: new approaches to rehabilitation. Meditsinskiy sovet = Medical Council:8, pages 209-216.
Crossref
Crossref
Sarina Gadgaard, Johanne A. Windeløv, Sine P. Schiellerup, Jens J. Holst, Bolette Hartmann & Mette M. Rosenkilde. (2023) Long-acting agonists of human and rodent GLP-2 receptors for studies of the physiology and pharmacological potential of the GLP-2 system. Biomedicine & Pharmacotherapy 160, pages 114383.
Crossref
Crossref
Palle Bekker Jeppesen. 2023. Intestinal Failure. Intestinal Failure
681
697
.
Ozren Stojanović, Irene Miguel-Aliaga & Mirko Trajkovski. (2022) Intestinal plasticity and metabolism as regulators of organismal energy homeostasis. Nature Metabolism 4:11, pages 1444-1458.
Crossref
Crossref
Nyan Abdalqadir & Khosrow Adeli. (2022) GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk. Microorganisms 10:10, pages 2061.
Crossref
Crossref
Sophie Greif, Sebastian Maasberg, Jan Wehkamp, Stefano Fusco, Yurdagül Zopf, Hans Joachim Herrmann, Georg Lamprecht, Torid Jacob, Ingolf Schiefke, Martin W. von Websky, Janine Büttner, Elisabeth Blüthner, Frank Tacke & Ulrich-Frank Pape. (2022) Long-term results of teduglutide treatment for chronic intestinal failure – Insights from a national, multi-centric patient home-care service program. Clinical Nutrition ESPEN 51, pages 222-230.
Crossref
Crossref
Maria Buur Nordskov Gabe, Lærke Smidt Gasbjerg, Sarina Gadgaard, Peter Lindquist, Jens Juul Holst & Mette Marie Rosenkilde. (2022) N‐terminal alterations turn the gut hormone GLP‐2 into an antagonist with gradual loss of GLP‐2 receptor selectivity towards more GLP‐1 receptor interaction. British Journal of Pharmacology 179:18, pages 4473-4485.
Crossref
Crossref
D. Dante Yeh, Georgia Vasileiou, Khaled Abdul Jawad, Gerd Daniel Pust & Patricia M. Byers. (2022) Teduglutide for the treatment of low-output enterocutaneous fistula – A pilot randomized controlled study. Clinical Nutrition ESPEN 50, pages 49-55.
Crossref
Crossref
Elisabeth M. Grande, Fitore Raka, Simon Hoffman & Khosrow Adeli. (2022) GLP-2 Regulation of Dietary Fat Absorption and Intestinal Chylomicron Production via Neuronal Nitric Oxide Synthase (nNOS) Signaling. Diabetes 71:7, pages 1388-1399.
Crossref
Crossref
Francesca Gigola, Maria Chiara Cianci, Roberto Cirocchi, Maria Chiara Ranucci, Marco Del Riccio, Riccardo Coletta & Antonino Morabito. (2022) Use of Teduglutide in Children With Intestinal Failure: A Systematic Review. Frontiers in Nutrition 9.
Crossref
Crossref
Fabio Bioletto, Chiara D’Eusebio, Fabio Dario Merlo, Umberto Aimasso, Marta Ossola, Marianna Pellegrini, Valentina Ponzo, Alessia Chiarotto, Antonella De Francesco, Ezio Ghigo & Simona Bo. (2022) Efficacy of Teduglutide for Parenteral Support Reduction in Patients with Short Bowel Syndrome: A Systematic Review and Meta-Analysis. Nutrients 14:4, pages 796.
Crossref
Crossref
L. N. Kostyuchenko & A. E. Lychkova. (2021) Rehabilitation aspects of nutritional correction after extensive combined sequity resection. Medical alphabet:35, pages 12-18.
Crossref
Crossref
Silvia Mazzuoli, Nunzia Regano, Stefania Lamacchia, Angela Silvestri & Francesco William Guglielmi. (2021) Intestinal iatrogenic hyperadaptation in patients with short bowel syndrome and Crohn's disease: Is this an indication for mandatory lifelong injections of teduglutide?. Nutrition 91-92, pages 111396.
Crossref
Crossref
Kirsa Skov-Jeppesen, Simon Veedfald, Sten Madsbad, Jens Juul Holst, Mette Marie Rosenkilde & Bolette Hartmann. (2021) Subcutaneous GIP and GLP-2 inhibit nightly bone resorption in postmenopausal women: A preliminary study. Bone 152, pages 116065.
Crossref
Crossref
Wout Verbeure, Harry van Goor, Hideki Mori, André P. van Beek, Jan Tack & Peter R. van Dijk. (2021) The Role of Gasotransmitters in Gut Peptide Actions. Frontiers in Pharmacology 12.
Crossref
Crossref
Hector Solar, Mariana Doeyo, Mariana Ortega, Silvia De Barrio, Estela Olano, Eduardo Moreira, Martin Buncuga, Alejandra Manzur, Adriana Crivelli & Gabriel Gondolesi. (2020) Postsurgical Intestinal Rehabilitation Using Semisynthetic Glucagon‐Like Peptide‐2 Analogue (sGLP‐2) at a Referral Center: Can Patients Achieve Parenteral Nutrition and sGLP‐2 Independency?. Journal of Parenteral and Enteral Nutrition 45:5, pages 1072-1082.
Crossref
Crossref
Nina L. HansenAndreas BrøndenChristina C. Nexøe-LarsenAlexander S. ChristensenDavid P. SonneJens F. RehfeldNicolai J. Wever AlbretchsenBolette HartmannTina VilsbøllJens J. HolstFilip K. Knop. (2020) Glucagon-Like Peptide 2 Inhibits Postprandial Gallbladder Emptying in Man: A Randomized, Double-Blinded, Crossover Study. Clinical and Translational Gastroenterology 11:12, pages e00257.
Crossref
Crossref
Meng-meng Ning, Wen-ji Yang, Wen-bo Guan, Yi-pei Gu, Ying Feng & Ying Leng. (2020) Dipeptidyl peptidase 4 inhibitor sitagliptin protected against dextran sulfate sodium-induced experimental colitis by potentiating the action of GLP-2. Acta Pharmacologica Sinica 41:11, pages 1446-1456.
Crossref
Crossref
Mark A. Fleming, Lubaina Ehsan, Sean R. Moore & Daniel E. Levin. (2020) The Enteric Nervous System and Its Emerging Role as a Therapeutic Target. Gastroenterology Research and Practice 2020, pages 1-13.
Crossref
Crossref
Palle Bekker Jeppesen, Simon M. Gabe, Douglas L. Seidner, Hak-Myung Lee & Clément Olivier. (2020) Citrulline correlations in short bowel syndrome–intestinal failure by patient stratification: Analysis of 24 weeks of teduglutide treatment from a randomized controlled study. Clinical Nutrition 39:8, pages 2479-2486.
Crossref
Crossref
Loris Pironi. (2019) Translation of Evidence Into Practice With Teduglutide in the Management of Adults With Intestinal Failure due to Short‐Bowel Syndrome: A Review of Recent Literature. Journal of Parenteral and Enteral Nutrition 44:6, pages 968-978.
Crossref
Crossref
Diane M. Hargrove, Sudarkodi Alagarsamy, Glenn Croston, Régent Laporte, Steve Qi, Karthik Srinivasan, Javier Sueiras-Diaz, Kazimierz Wiśniewski, Jennifer Hartwig, Mark Lu, Alexander P. Posch, Halina Wiśniewska, Claudio D. Schteingart, Pierre J.-M. Rivière & Violetta Dimitriadou. (2020) Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome. Journal of Pharmacology and Experimental Therapeutics 373:2, pages 193-203.
Crossref
Crossref
Samuel A. Kocoshis, Russell J. Merritt, Susan Hill, Susan Protheroe, Beth A. Carter, Simon Horslen, Simin Hu, Stuart S. Kaufman, David F. Mercer, Mikko P. Pakarinen, Robert S. Venick, Paul W. Wales & Andrew A. Grimm. (2019) Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24‐Week, Phase III Study. Journal of Parenteral and Enteral Nutrition 44:4, pages 621-631.
Crossref
Crossref
Ulrich-Frank Pape, Kishore R. Iyer, Palle B. Jeppesen, Marek Kunecki, Loris Pironi, Stéphane M. Schneider, Douglas L. Seidner, Hak-Myung Lee & John Caminis. (2020) Teduglutide for the treatment of adults with intestinal failure associated with short bowel syndrome: pooled safety data from four clinical trials. Therapeutic Advances in Gastroenterology 13, pages 175628482090576.
Crossref
Crossref
Kannayiram Alagiakrishnan & Darren Mah. 2020. Hypotensive Syndromes in Geriatric Patients. Hypotensive Syndromes in Geriatric Patients
9
21
.
Hung Pham, Laurence Trahair, Liza Phillips, Christopher Rayner, Michael Horowitz & Karen Jones. (2019) A randomized, crossover study of the acute effects of acarbose and gastric distension, alone and combined, on postprandial blood pressure in healthy older adults. BMC Geriatrics 19:1.
Crossref
Crossref
Bernardo Yusta, Dianne Matthews, Jacqueline A Koehler, Gemma Pujadas, Kiran Deep Kaur & Daniel J Drucker. (2019) Localization of Glucagon-Like Peptide-2 Receptor Expression in the Mouse. Endocrinology 160:8, pages 1950-1963.
Crossref
Crossref
Kirsa Skov-Jeppesen, Maria S. Svane, Christoffer Martinussen, Maria B.N. Gabe, Lærke S. Gasbjerg, Simon Veedfald, Kirstine N. Bojsen-Møller, Sten Madsbad, Jens J. Holst, Mette M. Rosenkilde & Bolette Hartmann. (2019) GLP-2 and GIP exert separate effects on bone turnover: A randomized, placebo-controlled, crossover study in healthy young men. Bone 125, pages 178-185.
Crossref
Crossref
Brandon B. Boland, Michael B. Mumphrey, Zheng Hao, R. Leigh Townsend, Benji Gill, Stephanie Oldham, Sarah Will, Christopher D. Morrison, Sangho Yu, Heike Münzberg, Christopher J. Rhodes, James L. Trevaskis & Hans-Rudolf Berthoud. (2019) Combined loss of GLP-1R and Y2R does not alter progression of high-fat diet-induced obesity or response to RYGB surgery in mice. Molecular Metabolism 25, pages 64-72.
Crossref
Crossref
Alvin T. George, Betty H. Li & Robert E. Carroll. (2019) Off-Label Teduglutide Therapy in Non-intestinal Failure Patients with Chronic Malabsorption. Digestive Diseases and Sciences 64:6, pages 1599-1603.
Crossref
Crossref
Nikolaj Nerup, Rikard Ambrus, Joanna Lindhe, Michael P. Achiam, Palle B. Jeppesen & Lars B. Svendsen. (2019) The effect of glucagon‐like peptide‐1 and glucagon‐like peptide‐2 on microcirculation: A systematic review. Microcirculation 26:3.
Crossref
Crossref
Nikolaj Nerup, Linea Landgrebe Ring, Rune Broni Strandby, Charlotte Egeland, Morten Bo Søndergaard Svendsen, Jane Preuss Hasselby, Gro Linno Willemoe, Bolette Hartmann, Lars Bo Svendsen & Michael Patrick Achiam. (2018) Quantitative perfusion assessment of intestinal anastomoses in pigs treated with glucagon-like peptide 2. Langenbeck's Archives of Surgery 403:7, pages 881-889.
Crossref
Crossref
Jennifer Taher, Christopher Baker, Danielle Alvares, Laraib Ijaz, Mahmood Hussain & Khosrow Adeli. (2018) GLP-2 Dysregulates Hepatic Lipoprotein Metabolism, Inducing Fatty Liver and VLDL Overproduction in Male Hamsters and Mice. Endocrinology 159:9, pages 3340-3350.
Crossref
Crossref
Adile Orhan, Ismail Gögenur & Hannelouise Kissow. (2018) The Intestinotrophic Effects of Glucagon-Like Peptide-2 in Relation to Intestinal Neoplasia. The Journal of Clinical Endocrinology & Metabolism 103:8, pages 2827-2837.
Crossref
Crossref
Patricia L. Brubaker. 2011. Comprehensive Physiology. Comprehensive Physiology
1185
1210
.
Jan de Laffolie, Hassan Y. Naim, Silvia Rudloff & Klaus‐Peter Zimmer. (2018) Starch Tolerance and the Short Bowel. Journal of Pediatric Gastroenterology and Nutrition 66:S3.
Crossref
Crossref
Palle B. Jeppesen, Simon M. Gabe, Douglas L. Seidner, Hak-Myung Lee & Clément Olivier. (2018) Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure. Gastroenterology 154:4, pages 874-885.
Crossref
Crossref
Marc Schoeler, Thomas Klag, Judith Wendler, Simon Bernhard, Michael Adolph, Andreas Kirschniak, Martin Goetz, Nisar Malek & Jan Wehkamp. (2018) GLP-2 analog teduglutide significantly reduces need for parenteral nutrition and stool frequency in a real-life setting. Therapeutic Advances in Gastroenterology 11, pages 175628481879334.
Crossref
Crossref
Jane K. Naberhuis, Andrew S. Deutsch & Kelly A. Tappenden. (2015) Teduglutide‐Stimulated Intestinal Adaptation Is Complemented and Synergistically Enhanced by Partial Enteral Nutrition in a Neonatal Piglet Model of Short Bowel Syndrome. Journal of Parenteral and Enteral Nutrition 41:5, pages 853-865.
Crossref
Crossref
Pernille Wismann, Pernille Barkholt, Thomas Secher, Niels Vrang, Henrik B. Hansen, Palle Bekker Jeppesen, Laurie L. Baggio, Jacqueline A. Koehler, Daniel J. Drucker, Darleen A. Sandoval & Jacob Jelsing. (2017) The endogenous preproglucagon system is not essential for gut growth homeostasis in mice. Molecular Metabolism 6:7, pages 681-692.
Crossref
Crossref
Stanisław Klek, Marek Kunecki, Jacek Sobocki, Konrad Matysiak, Katarzyna Karwowska & Krystyna Urbanowicz. (2017) The Polish Intestinal Failure Centres’ consensus on the use of teduglutide for the treatment of short bowel syndrome. Nutrition 38, pages 28-33.
Crossref
Crossref
Lasse Bremholm, Ulrik B. Andersen, Mads Hornum, Linda Hilsted, Simon Veedfald, Bolette Hartmann & Jens Juul Holst. (2017)
Acute effects of glucagon-like peptide-1, GLP-1
9-36 amide
, and exenatide on mesenteric blood flow, cardiovascular parameters, and biomarkers in healthy volunteers
. Physiological Reports 5:4, pages e13102.
Crossref
Crossref
John B. Furness & Jeremy J. Cottrell. (2017) Signalling from the gut lumen. Animal Production Science 57:11, pages 2175.
Crossref
Crossref
Gemma Pujadas & Daniel J. Drucker. (2016) Vascular Biology of Glucagon Receptor Superfamily Peptides: Mechanistic and Clinical Relevance. Endocrine Reviews 37:6, pages 554-583.
Crossref
Crossref
Johanna Iturrino, Michael Camilleri, Andres Acosta, Jessica O'Neill, Duane Burton, Jithinraj Edakkanambeth Varayil, Paula J. Carlson, Alan R. Zinsmeister & Ryan Hurt. (2015) Acute Effects of a Glucagon‐Like Peptide 2 Analogue, Teduglutide, on Gastrointestinal Motor Function and Permeability in Adult Patients With Short Bowel Syndrome on Home Parenteral Nutrition. Journal of Parenteral and Enteral Nutrition 40:8, pages 1089-1095.
Crossref
Crossref
Jane K. Naberhuis & Kelly A. Tappenden. (2015) Teduglutide for Safe Reduction of Parenteral Nutrient and/or Fluid Requirements in Adults. Journal of Parenteral and Enteral Nutrition 40:8, pages 1096-1105.
Crossref
Crossref
Brad W. Warner. (2016) The Pathogenesis of Resection-Associated Intestinal Adaptation. Cellular and Molecular Gastroenterology and Hepatology 2:4, pages 429-438.
Crossref
Crossref
Jane Naberhuis & Kelly Tappenden. 2016. Short Bowel Syndrome. Short Bowel Syndrome
43
54
.
Antonella Amato, Sara Baldassano & Flavia Mulè. (2016) GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity. Journal of Endocrinology 229:2, pages R57-R66.
Crossref
Crossref
Kazimierz Wiśniewski, Javier Sueiras-Diaz, Guangcheng Jiang, Robert Galyean, Mark Lu, Dorain Thompson, Yung-Chih Wang, Glenn Croston, Alexander Posch, Diane M. Hargrove, Halina Wiśniewska, Régent Laporte, John J. Dwyer, Steve Qi, Karthik Srinivasan, Jennifer Hartwig, Nicky Ferdyan, Monica Mares, John Kraus, Sudarkodi Alagarsamy, Pierre J. M. Rivière & Claudio D. Schteingart. (2016) Synthesis and Pharmacological Characterization of Novel Glucagon-like Peptide-2 (GLP-2) Analogues with Low Systemic Clearance. Journal of Medicinal Chemistry 59:7, pages 3129-3139.
Crossref
Crossref
Palle Bekker Jeppesen. 2016. Current Concepts of Intestinal Failure. Current Concepts of Intestinal Failure
79
96
.
Naci Topaloğlu, Adem Küçük, Şule Yıldırım, Mustafa Tekin, Havva Erdem & Mustafa Deniz. (2015) Glucagon-like peptide-2 exhibits protective effect on hepatic ischemia-reperfusion injury in rats. Frontiers of Medicine 9:3, pages 368-373.
Crossref
Crossref
M. Tekin, N. Topaloğlu, A. Küçük, M. Deniz, Ş. Yıldırım & H. Erdem. (2015) Protective effect of glucagon-like peptide-2 in experimental corrosive esophagitis. Diseases of the Esophagus 28:3, pages 258-261.
Crossref
Crossref
E. E. Connor, C. M. Evock-Clover, M. P. Walker, T. H. Elsasser & S. Kahl. (2015) COMPARATIVE GUT PHYSIOLOGY SYMPOSIUM: Comparative physiology of glucagon-like peptide-2: Implications and applications for production and health of ruminants12. Journal of Animal Science 93:2, pages 492-501.
Crossref
Crossref
Palle B. Jeppesen. (2015) Gut hormones in the treatment of short-bowel syndrome and intestinal failure. Current Opinion in Endocrinology & Diabetes and Obesity 22:1, pages 14-20.
Crossref
Crossref
Guldal Gulec Suyen, Naciye Isbil-Buyukcoskun, Betul Cam & Kasim Ozluk. (2015) Effects of centrally injected glucagon-like peptide-2 on gastric mucosal blood flow in rats: Possible mechanisms. Peptides 64, pages 62-66.
Crossref
Crossref
Roberto Vettor, Roberto Fabris & Marco Rossato. 2015. Multidisciplinary Approach to Obesity. Multidisciplinary Approach to Obesity
13
30
.
Palle Bekker Jeppesen. 2015. Diet and Nutrition in Critical Care. Diet and Nutrition in Critical Care
1913
1927
.
Laurence G. Trahair, Michael Horowitz & Karen L. Jones. (2014) Postprandial Hypotension: A Systematic Review. Journal of the American Medical Directors Association 15:6, pages 394-409.
Crossref
Crossref
Palle B. Jeppesen. (2014) New approaches to the treatments of short bowel syndrome-associated intestinal failure. Current Opinion in Gastroenterology 30:2, pages 182-188.
Crossref
Crossref
Daniel J. DruckerBernardo Yusta. (2014) Physiology and Pharmacology of the Enteroendocrine Hormone Glucagon-Like Peptide-2. Annual Review of Physiology 76:1, pages 561-583.
Crossref
Crossref
Palle Bekker Jeppesen. 2014. Diet and Nutrition in Critical Care. Diet and Nutrition in Critical Care
1
17
.
John B. Furness, Leni R. Rivera, Hyun-Jung Cho, David M. Bravo & Brid Callaghan. (2013) The gut as a sensory organ. Nature Reviews Gastroenterology & Hepatology 10:12, pages 729-740.
Crossref
Crossref
Ryo Sueyoshi, Matthew W. Ralls & Daniel H. Teitelbaum. (2013) Glucagon-like peptide 2 increases efficacy of distraction enterogenesis. Journal of Surgical Research 184:1, pages 365-373.
Crossref
Crossref
Palle B. Jeppesen. (2013) Modern treatment of short bowel syndrome. Current Opinion in Clinical Nutrition and Metabolic Care, pages 1.
Crossref
Crossref
Kathryn J. Rowland, Pamela M. Choi & Brad W. Warner. (2013) The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis. Seminars in Pediatric Surgery 22:2, pages 101-111.
Crossref
Crossref
Sara Baldassano, Antonella Amato, Francesco Cappello, Francesca Rappa & Flavia Mulè. (2013) Glucagon-like peptide-2 and mouse intestinal adaptation to a high-fat diet. Journal of Endocrinology 217:1, pages 11-20.
Crossref
Crossref
Douglas L. Seidner, Lauren K. Schwartz, Marion F. Winkler, Khursheed Jeejeebhoy, Joseph I. Boullata & Kelly A. Tappenden. (2013) Increased Intestinal Absorption in the Era of Teduglutide and Its Impact on Management Strategies in Patients With Short Bowel Syndrome–Associated Intestinal Failure. Journal of Parenteral and Enteral Nutrition 37:2, pages 201-211.
Crossref
Crossref
Takeshi Fukushima, Masato Asahina, Yoshikatsu Fujinuma, Yoshitaka Yamanaka, Akira Katagiri, Masahiro Mori & Satoshi Kuwabara. (2012) Role of intestinal peptides and the autonomic nervous system in postprandial hypotension in patients with multiple system atrophy. Journal of Neurology 260:2, pages 475-483.
Crossref
Crossref
P. Janssen, A. Rotondo, F. Mulé & J. Tack. (2012) Review article: a comparison of glucagon‐like peptides 1 and 2. Alimentary Pharmacology & Therapeutics 37:1, pages 18-36.
Crossref
Crossref
P. Høyerup, P.M. Hellström, P.T. Schmidt, C.F. Brandt, C. Askov-Hansen, P.B. Mortensen & P.B. Jeppesen. (2013) Glucagon-like peptide-2 stimulates mucosal microcirculation measured by laser Doppler flowmetry in end-jejunostomy short bowel syndrome patients. Regulatory Peptides 180, pages 12-16.
Crossref
Crossref
Alan L. Buchman. (2012) Teduglutide and Short Bowel Syndrome: Every Night Without Parenteral Fluids Is a Good Night. Gastroenterology 143:6, pages 1416-1420.
Crossref
Crossref
Silvina S. M. Villanueva, Virginia G. Perdomo, María L. Ruiz, Juan P. Rigalli, Agostina Arias, Marcelo G. Luquita, Mary Vore, Viviana A. Catania & Aldo D. Mottino. (2012) Effect of Glucagon-Like Peptide 2 on Hepatic, Renal, and Intestinal Disposition of 1-Chloro-2,4-dinitrobenzene. Drug Metabolism and Disposition 40:7, pages 1252-1258.
Crossref
Crossref
Palle Bekker Jeppesen. (2012) Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome. Therapeutic Advances in Gastroenterology 5:3, pages 159-171.
Crossref
Crossref
Seung-Jun Lee, Jennifer Lee, Karen K. Li, Dianne Holland, Heather Maughan, David S. Guttman, Bernardo Yusta & Daniel J. Drucker. (2012) Disruption of the Murine Glp2r Impairs Paneth Cell Function and Increases Susceptibility to Small Bowel Enteritis. Endocrinology 153:3, pages 1141-1151.
Crossref
Crossref
C.C. Taylor-Edwards, D.G. Burrin, N.B. Kristensen, J.J. Holst, K.R. McLeod & D.L. Harmon. (2012) Glucagon-like peptide-2 (GLP-2) increases net amino acid utilization by the portal-drained viscera of ruminating calves. Animal 6:12, pages 1985-1997.
Crossref
Crossref
Peter Holzer. 2012. Physiology of the Gastrointestinal Tract. Physiology of the Gastrointestinal Tract
817
845
.
D. Gentilcore, L. Vanis, J. M. Wishart, C. K. Rayner, M. Horowitz & K. L. Jones. (2011) The Alpha ( )-Glucosidase Inhibitor, Acarbose, Attenuates the Blood Pressure and Splanchnic Blood Flow Responses to Intraduodenal Sucrose in Older Adults. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 66A:8, pages 917-924.
Crossref
Crossref
Alessandra Rotondo, Antonella Amato, Sara Baldassano, Laura Lentini & Flavia Mulè. (2011) Gastric relaxation induced by glucagon-like peptide-2 in mice fed a high-fat diet or fasted. Peptides 32:8, pages 1587-1592.
Crossref
Crossref
Katherine J. Rowland & Patricia L. Brubaker. (2011) The “cryptic” mechanism of action of glucagon-like peptide-2. American Journal of Physiology-Gastrointestinal and Liver Physiology 301:1, pages G1-G8.
Crossref
Crossref
Lasse Bremholm, Mads Hornum, Ulrik B. Andersen, Bolette Hartmann, Jens Juul Holst & Palle Bekker Jeppesen. (2011) The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients. Regulatory Peptides 168:1-3, pages 32-38.
Crossref
Crossref
C.C. Taylor-Edwards, D.G. Burrin, J.J. Holst, K.R. McLeod & D.L. Harmon. (2011) Glucagon-like peptide-2 (GLP-2) increases small intestinal blood flow and mucosal growth in ruminating calves. Journal of Dairy Science 94:2, pages 888-898.
Crossref
Crossref
Jasmine Bahrami, Christine Longuet, Laurie L. Baggio, Karen Li & Daniel J. Drucker. (2010) Glucagon-Like Peptide-2 Receptor Modulates Islet Adaptation to Metabolic Stress in the ob/ob Mouse. Gastroenterology 139:3, pages 857-868.
Crossref
Crossref
Mads Hornum, Jan F. Pedersen, Steen Larsen, Ole Olsen, Jens J. Holst & Filip K. Knop. (2010) Increased Postprandial Response of Glucagon-Like Peptide-2 in Patients with Chronic Pancreatitis and Pancreatic Exocrine Insufficiency. Pancreatology 10:2-3, pages 201-207.
Crossref
Crossref
Alan L. Buchman, Seymour Katz, John C. Fang, Charles N. Bernstein & Souheil G. Abou-Assi. (2010) Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohnʼs disease. Inflammatory Bowel Diseases 16:6, pages 962-973.
Crossref
Crossref
Mark E. McMellen, Derek Wakeman, Shannon W. Longshore, Lucas A. McDuffie & Brad W. Warner. (2010) Growth factors: possible roles for clinical management of the short bowel syndrome. Seminars in Pediatric Surgery 19:1, pages 35-43.
Crossref
Crossref
Lasse Bremholm, Mads Hornum, Ulrik B. Andersen & Jens Juul Holst. (2010) The effect of glucagon-like peptide-2 on arterial blood flow and cardiac parameters. Regulatory Peptides 159:1-3, pages 67-71.
Crossref
Crossref
Roman Iakoubov, Lina M. Lauffer, Shivangi Trivedi, Young-In J. Kim & Patricia L. Brubaker. (2009) Carcinogenic Effects of Exogenous and Endogenous Glucagon-Like Peptide-2 in Azoxymethane-Treated Mice. Endocrinology 150:9, pages 4033-4043.
Crossref
Crossref
Katharina Wallis, Julian RF Walters & Simon Gabe. (2009) Short bowel syndrome: the role of GLP-2 on improving outcome. Current Opinion in Clinical Nutrition & Metabolic Care 12:5, pages 526-532.
Crossref
Crossref